/C O R R E C T I O N -- Beckman Coulter Diagnostics/
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Danaher (DHR) Announces Beckman Coulter s SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from the FDA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Clinical laboratories prepare for coronavirus variants
Adam Bonislawski, 360Dx
NEW
YORK
– As new variants of SARS-CoV-2 continue to emerge, clinical labs are having to develop new and evolve existing approaches to test for the virus.
While existing molecular tests appear to be capable of detecting the new UK and South Africa SARS-Cov-2 strains that have been the focus of much recent attention and concern, the appearance of these and other variants could require changes in labs testing processes and the development of better tools for monitoring the presence of relevant variants in the patients they serve.
The most immediate concern from a lab s perspective is that the mutations that characterize major SARS-CoV-2 variants may make molecular or antigen tests for detecting the virus less effective by altering the regions of RNA or protein these tests target.